| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |